Objectives To study changes in cytokine levels and radiographic findings (mTSS) in rheumatoid arthritis (RA) patients newly treated with etanercept (ETA).
Methods In our 19 pts who started ETA during Nov/2005 - Jan/2007 (2 men; mean age, 62.0 yo; mean disease duration, 8.7 yrs), cytokine (IL-4, IL-6, IL-8, TNFa) levels were determined at baseline, week 4, 24 to assess relationship of RA activity and radiographic findings.
Results Mean DAS28 (ESR) at baseline, & week 4, 24: 6.7, 5.0, 3.8 respectively. Compared to baseline, TNFaat week 24 significantly increased (2.3 vs 96.9). IL-6 significantly decreased (37.4 vs 9.73). Mean mTSS was 92±62 at baseline and 94±64 at week 24; 9 pts achieved radiographic remission (ΔmTSS ≤0.5). Analysis of factors affecting radiographic remission showed no significant variable of patient’s background. Cytokine levels in the remission group appeared to be lower at week 24: IL-4 (91 vs 351), IL-6 (6.8 vs 12.4), IL-8 (5.0 vs 10.8), TNFa (91.0 vs 102.2), but no significant difference.
Conclusions We evaluated the relationship between radiographic remission and cytokine changes in the course of ETA treatment. Although the remission group had a decreasing tendency of IL-4, IL-6, IL-8, TNFaat week 24, no significant difference was seen.
Disclosure of Interest None Declared